Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00222729 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00222729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00222729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Lead sponsor
University of Pittsburgh
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2005
Completion date
October 31, 2013
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer